Is the use of piperacillin/tazobactam for bacteremia caused by ceftriaxone-nonsusceptible Escherichia coli and Klebsiella pneumoniae an obsolete practice?
Kylie Pritchard, PharmD, BCPS-AQ ID
Advertisement
Articles by Kylie Pritchard, PharmD, BCPS-AQ ID
Advertisement
Latest Updated Articles
Lessons From the MERINO TrialPublished: November 9th 2018 | Updated:
Advertisement
Advertisement
Trending on Contagion Live
1
Rapid HCV Test Provides Opportunity for Single Visit Diagnosis and Treatment Encounters
2
Phage and Antibiotic Combination Therapy for Biofilm-Associated Bacterial Infections
3
Clinical Takeaways From ViiV’s PASO DOBLE and CLARITY Studies
4
Balancing Early Discharge and Follow-Up Challenges in Skin Infection Care
5
